FibroGen, Inc. (NASDAQ:FGEN) Q3 2024 Earnings Call Transcript
Operator: Good day and welcome to the FibroGen Third Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode.
Fibrogen Inc (FGEN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 6,800,000 | $3,600,600 | 0.04% | |
| 2. | 683 Capital Partners Ari Zweiman | 2,138,402 | $1,132,284 | 0.07% | |
| 3. | Renaissance Technologies Jim Simons | 1,358,712 | $719,438 | +81% | 0% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,265,515 | $670,721 | -13% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 878,400 | $465,113 | +19% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.17 | 22,123 | 82,123 | 2024-06-12 | Filing | ||
| $1.91 | 50,000 | 470,178 | 2024-03-07 | Filing | ||
| $11.53 | 3,100 | Officer | 48,816 | 2021-08-26 | Filing | |
| $35.28 | 19,800 | Officer, Director | 27,800 | 2020-06-11 | Filing | |
| $36.29 | 8,000 | Officer, Director | 8,000 | 2020-06-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.03 | 2,000 | Director | 28,866 | 2023-09-01 | Filing | |
| $1.91 | 2,000 | Director | 30,866 | 2023-08-04 | Filing | |
| $2.69 | 2,000 | Director | 32,866 | 2023-07-11 | Filing | |
| $2.80 | 1,880 | Officer, Director | 374,722 | 2023-07-07 | Filing | |
| $16.53 | 791 | Officer | 108,261 | 2023-06-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,876,976 | $3,114,797 | 0% | |
| 2. | 4,616,130 | $2,444,242 | 0% | |
| 3. | 2,377,036 | $1,258,639 | 0% | |
| 4. | 1,058,348 | $560,549 | 0% | |
| 5. | 604,421 | $320,041 | 0% |
News See All
FibroGen, Inc. (NASDAQ:FGEN) Q2 2024 Earnings Call Transcript
Operator: Good day and welcome to the FibroGen Second Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript
FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.33272 EPS, expectations were $-0.31.
FibroGen, Inc. (NASDAQ:FGEN) Q4 2023 Earnings Call Transcript
FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.57 EPS, expectations were $-0.42. FibroGen, Inc.
FibroGen, Inc. (NASDAQ:FGEN) Q3 2023 Earnings Call Transcript
Operator: Hello and welcome to the FibroGen's Third Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode.
FibroGen, Inc. (NASDAQ:FGEN) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the FibroGen's Second Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode.
FibroGen, Inc. (NASDAQ:FGEN) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to FibroGen's First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
FibroGen, Inc. (NASDAQ:FGEN) Q4 2022 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to FibroGen's Fourth Quarter and Full Year 2022 Financial Results Earnings Call. . I would now like to hand the call over to your host, Mike Tung.
5 Stocks Under $30 to Buy Today According to Billionaire Steven Cohen
In this piece, we will look at the ten stocks under $30 to buy today according to billionaire Steven Cohen.
Billionaire Hedge Funds
